Related Experiment Video
Updated: May 1, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 11, 2015
Treatment of tobacco addiction and the cardiovascular specialist
1Department of Cardiology and Pneumology, University Medical Centre Göttingen, Gottingen, Germany. raupach@med.uni-goettingen.de
Insights
Quitting smoking significantly reduces cardiovascular disease (CVD) risks and mortality. Cardiovascular specialists are crucial in guiding smokers with CVD towards cessation and advocating for tobacco control policies.
Area of Science:
- Cardiology
- Public Health
- Addiction Medicine
Background:
- Tobacco smoking is a primary cause of preventable deaths globally, with cardiovascular disease (CVD) accounting for half of these fatalities.
- Physicians managing CVD are vital in aiding smokers with cardiovascular disorders to quit.
Purpose of the Study:
- To review current evidence on smoking as a CVD risk factor.
- To examine smoking cessation's impact on CVD patient prognosis.
- To explore drug interactions, cessation interventions, and tobacco control policies for CVD patients.
Main Methods:
- Literature review of recent findings on smoking and cardiovascular disease.
- Analysis of smoking cessation effects on CVD outcomes.
- Evaluation of interventions and policy implications.
Main Results:
- Smoking cessation post-cardiovascular event substantially lowers morbidity and mortality.
- CVD mortality declines are primarily due to risk factor modification, not solely medical treatment improvements.
- Smokers experience reduced treatment efficacy and higher medication nonadherence; effective cessation interventions exist.
Conclusions:
- Cardiovascular specialists can significantly promote cardiovascular health individually and population-wide.
- Encouraging policy-makers for tobacco control action is recommended.
Purpose Of Review:
Tobacco smoking is the leading cause of avoidable deaths worldwide, and half of these deaths are due to cardiovascular disease (CVD). Physicians specialized in the management of CVD play a key role in ensuring that all smokers with cardiovascular disorders are offered best evidence support to help them quit smoking. This review summarizes recent findings on smoking as a risk factor for CVD, effects of smoking cessation on the prognosis of CVD patients, interactions between drug treatment for CVD and smoking, effective interventions to promote quitting in CVD patients and policy issues regarding tobacco control.
Recent Findings:
Smoking cessation following an acute cardiovascular event yields a substantial reduction in morbidity and mortality. Recent declines in CVD mortality were mainly a result of risk factor modification rather than improvement of medical treatments for CVD. The latter are also less effective in smokers than in nonsmokers, and smokers are at high risk of medication nonadherence. Effective interventions to support quit attempts in smokers with CVD are available. Cardiovascular specialists should encourage policy-makers to take appropriate tobacco control action.
Summary:
Cardiovascular specialists are in a unique position to promote cardiovascular health at the individual as well as at a population level.
More Related Videos
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Cardiomyopathy V: Interprofessional Care
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care

